Skip to main content
Clinical Trials/CTRI/2024/07/069772
CTRI/2024/07/069772
Not yet recruiting
Phase 3

A controlled clinical study to evaluate the efficacy of Vranaropani (Hemigraphis alternata (Burm.f)) Malahara in the management of sadyovrana. - nil

Dr Surender Redhu0 sites0 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Dr Surender Redhu
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
Dr Surender Redhu

Eligibility Criteria

Inclusion Criteria

  • Patients of age group between 16 to 70 yrs.
  • Kshataja vrana, Chinna vrana.
  • Sadyovrana of following dimensions:
  • Maximum length 5 cm.
  • Maximum width: 5 cm
  • Maximum Depth: 0\.5 cm.
  • Patients of either gender.
  • Wounds within 7 days.

Exclusion Criteria

  • Patients with systemic disorders like DM, HTN, Bleeding disorders and dermatological manifestations.
  • Wounds that require suturing.
  • Dushta Vrana (Infected).
  • The patients having Sadyovrana with other complications like fractures Marmaghata etc.
  • Medico\-legal cases

Outcomes

Primary Outcomes

Not specified

Similar Trials